Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands

BACKGROUND: People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. The efficacy of HCV treatment has significantly improved in recent years with the introduction of direct-acting antivirals (DAAs). However, DAAs are more costly than pegylated-interfer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: van Santen, Daniëla K., de Vos, Anneke S., Matser, Amy, Willemse, Sophie B., Lindenburg, Karen, Kretzschmar, Mirjam E. E., Prins, Maria, de Wit, G. Ardine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053429/
https://ncbi.nlm.nih.gov/pubmed/27711200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0163488
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia